Adjusting for demographics and hours/weeks of work, we found that on average female physicians earn about 9% less than their male counterparts, finds health economist Boris Kralj.
With an ongoing phase 3 study, pralsetinib seems to be a promising candidate for the treatment of different types of cancer because of the presence of oncogenic rearranged during transfection) fusions.
Patients and their families have rallied behind the drug from Amylyx Pharma, launching an aggressive lobbying campaign and enlisting members of Congress to push the U.S. Food and Drug Administration to grant approval.
